By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company ANGLE plc

ANGLE plc (ANPCY)

OTC Market Data in USD, Fundamentals in GBP
$0.86
+$0.02
+1.99%
Last Update: 29 Aug 2025, 17:34
$24.47M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.61 - $2.39
52 Week Range

ANPCY Stock Price Chart

Explore ANGLE plc interactive price chart. Choose custom timeframes to analyze ANPCY price movements and trends.

ANPCY Company Profile

Discover essential business fundamentals and corporate details for ANGLE plc (ANPCY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

28 Apr 2015

Employees

150.00

CEO

Andrew David William Newland ACA, Meng

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

ANPCY Financial Timeline

Browse a chronological timeline of ANGLE plc corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 28 May 2025

EPS came in at -$0.01 , while revenue for the quarter reached $1.14M .

Earnings released on 24 Oct 2024

Earnings released on 26 Sept 2024

EPS came in at -$0.02 , while revenue for the quarter reached $654.37K .

Earnings released on 5 Jun 2024

EPS came in at -$0.02 , while revenue for the quarter reached $648.89K .

Earnings released on 19 Mar 2024

EPS came in at -$0.05 , while revenue for the quarter reached $1.25M .

Earnings released on 7 Feb 2024

EPS came in at -$0.02 , while revenue for the quarter reached $602.07K .

Earnings released on 30 Jun 2023

EPS came in at -$0.05 , while revenue for the quarter reached $1.51M .

Earnings released on 21 Apr 2023

EPS came in at -$0.06 , while revenue for the quarter reached $764.48K .

Earnings released on 31 Mar 2023

EPS came in at -$0.02 , while revenue for the quarter reached $739.17K .

Earnings released on 30 Sept 2022

EPS came in at -$0.03 , while revenue for the quarter reached $344.08K .

Earnings released on 30 Jun 2022

EPS came in at -$0.05 , while revenue for the quarter reached $508.61K .

Earnings released on 31 Mar 2022

EPS came in at -$0.03 , while revenue for the quarter reached $274.77K .

Earnings released on 31 Dec 2021

EPS came in at -$0.04 , while revenue for the quarter reached $967.18K .

Earnings released on 30 Sept 2021

EPS came in at -$0.02 , while revenue for the quarter reached $484.26K .

Earnings released on 30 Jun 2021

EPS came in at -$0.05 , while revenue for the quarter reached $409.00K .

Earnings released on 31 Mar 2021

EPS came in at -$0.02 , while revenue for the quarter reached $204.47K .

Earnings released on 31 Dec 2020

EPS came in at -$0.05 , while revenue for the quarter reached $716.85K .

Earnings released on 30 Sept 2020

EPS came in at -$0.03 , while revenue for the quarter reached $340.09K .

ANPCY Stock Performance

Access detailed ANPCY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run